Sino Biopharmaceutical Statistics

Total Valuation

HKG:1177 has a market cap or net worth of HKD 71.57 billion. The enterprise value is 77.65 billion.

Market Cap	71.57B
Enterprise Value	77.65B

Important Dates

The next estimated earnings date is Friday, May 16, 2025.

Earnings Date	May 16, 2025
Ex-Dividend Date	Jun 16, 2025

Share Statistics

HKG:1177 has 17.89 billion shares outstanding. The number of shares has decreased by -2.36% in one year.

Current Share Class	17.89B
Shares Outstanding	17.89B
Shares Change (YoY)	-2.36%
Shares Change (QoQ)	-1.25%
Owned by Insiders (%)	50.56%
Owned by Institutions (%)	17.99%
Float	8.85B

Valuation Ratios

The trailing PE ratio is 35.84 and the forward PE ratio is 20.83. HKG:1177's PEG ratio is 1.36.

PE Ratio	35.84
Forward PE	20.83
PS Ratio	2.33
PB Ratio	1.57
P/TBV Ratio	2.19
P/FCF Ratio	11.89
P/OCF Ratio	10.17
PEG Ratio	1.36

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.64, with an EV/FCF ratio of 12.90.

EV / Earnings	20.85
EV / Sales	2.53
EV / EBITDA	10.64
EV / EBIT	12.84
EV / FCF	12.90

Financial Position

The company has a current ratio of 1.26, with a Debt / Equity ratio of 0.23.

Current Ratio	1.26
Quick Ratio	1.11
Debt / Equity	0.23
Debt / EBITDA	1.39
Debt / FCF	1.72
Interest Coverage	19.66

Financial Efficiency

Return on equity (ROE) is 11.82% and return on invested capital (ROIC) is 7.02%.

Return on Equity (ROE)	11.82%
Return on Assets (ROA)	5.62%
Return on Invested Capital (ROIC)	7.02%
Return on Capital Employed (ROCE)	12.65%
Revenue Per Employee	1.26M
Profits Per Employee	152,772
Employee Count	24,379
Asset Turnover	0.45
Inventory Turnover	2.44

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +30.72% in the last 52 weeks. The beta is 0.73, so HKG:1177's price volatility has been lower than the market average.

Beta (5Y)	0.73
52-Week Price Change	+30.72%
50-Day Moving Average	3.65
200-Day Moving Average	3.34
Relative Strength Index (RSI)	61.37
Average Volume (20 Days)	84,565,311

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1177 had revenue of HKD 30.72 billion and earned 3.72 billion in profits. Earnings per share was 0.20.

Revenue	30.72B
Gross Profit	25.04B
Operating Income	6.17B
Pretax Income	5.62B
Net Income	3.72B
EBITDA	7.34B
EBIT	6.17B
Earnings Per Share (EPS)	0.20

Full Income Statement

Balance Sheet

The company has 15.77 billion in cash and 10.33 billion in debt, giving a net cash position of 5.44 billion or 0.30 per share.

Cash & Cash Equivalents	15.77B
Total Debt	10.33B
Net Cash	5.44B
Net Cash Per Share	0.30
Equity (Book Value)	45.52B
Book Value Per Share	1.90
Working Capital	5.46B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.04 billion and capital expenditures -1.02 billion, giving a free cash flow of 6.02 billion.

Operating Cash Flow	7.04B
Capital Expenditures	-1.02B
Free Cash Flow	6.02B
FCF Per Share	0.34

Full Cash Flow Statement

Margins

Gross margin is 81.51%, with operating and profit margins of 20.10% and 12.12%.

Gross Margin	81.51%
Operating Margin	20.10%
Pretax Margin	18.28%
Profit Margin	12.12%
EBITDA Margin	23.88%
EBIT Margin	20.10%
FCF Margin	19.59%

Dividends & Yields

This stock pays an annual dividend of 0.08, which amounts to a dividend yield of 2.08%.

Dividend Per Share	0.08
Dividend Yield	2.08%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	52.76%
Buyback Yield	2.36%
Shareholder Yield	4.45%
Earnings Yield	5.20%
FCF Yield	8.41%

Dividend Details

Stock Splits

The last stock split was on July 20, 2020. It was a forward split with a ratio of 1.5.

Last Split Date	Jul 20, 2020
Split Type	Forward
Split Ratio	1.5

Scores

HKG:1177 has an Altman Z-Score of 2.75. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.75
Piotroski F-Score	n/a